The measurement of physical functioning among patients with Tenosynovial Giant Cell Tumor (TGCT) using the Patient-Reported Outcomes Measurement Information System (PROMIS)
Abstract Background Tenosynovial giant cell tumor (TGCT), a rare, locally aggressive neoplasm of the synovium of joints and tendon sheaths, is associated with joint destruction, pain and swelling. Impacts on physical function (PF) vary depending on tumor size and location. The aim of this study was...
Saved in:
Main Authors: | Heather L. Gelhorn (Author), Xin Ye (Author), Rebecca M. Speck (Author), Sandra Tong (Author), John H. Healey (Author), Susan V. Bukata (Author), Richard D. Lackman (Author), Lindsey Murray (Author), Grant Maclaine (Author), William R. Lenderking (Author), Henry H. Hsu (Author), Paul S. Lin (Author), William D. Tap (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2019-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psychometric properties of a custom Patient-Reported Outcomes Measurement Information System (PROMIS) physical function short form and worst stiffness numeric rating scale in tenosynovial giant cell tumors
by: Rebecca M. Speck, et al.
Published: (2020) -
Exposure-response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor
by: Ophelia Yin, et al.
Published: (2021) -
Tenosynovial Giant Cell Tumor Arising on the Scapular Region
by: Asako Fukuda, et al.
Published: (2013) -
Intramuscular Tenosynovial Giant Cell Tumor, Diffuse-Type
by: Yoo Jin Lee, et al.
Published: (2016) -
Overview of Pharmacological Therapies for Diffuse Tenosynovial Giant Cell Tumor
by: Antonia Stamatiou, et al.
Published: (2023)